OTCPK:ACNV

Stock Analysis Report

Executive Summary

Accelera Innovations, Inc., a healthcare service company, focuses on the development of Internet-based software in the United States.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Accelera Innovations has significant price volatility in the past 3 months.
  • Accelera Innovations's last earnings update was 684 days ago.
  • Accelera Innovations is not covered by any analysts.

Share Price & News

How has Accelera Innovations's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-29.7%

OTCPK:ACNV

1.1%

US Healthcare Services

1.3%

US Market


1 Year Return

-35.6%

OTCPK:ACNV

6.6%

US Healthcare Services

2.0%

US Market

ACNV underperformed the Healthcare Services industry which returned 4.8% over the past year.

ACNV underperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

ACNVIndustryMarket
7 Day-29.7%1.1%1.3%
30 Day-7.2%-5.5%3.9%
90 Day4.0%-4.9%3.4%
1 Year-35.6%-35.6%6.7%6.6%4.2%2.0%
3 Year-90.7%-90.7%49.4%49.1%47.2%37.6%
5 Yearn/a47.0%46.1%60.5%42.9%

Price Volatility Vs. Market

How volatile is Accelera Innovations's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Accelera Innovations undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Accelera Innovations is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Accelera Innovations has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Accelera Innovations's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Accelera Innovations regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Accelera Innovations expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

28.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Accelera Innovations has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Accelera Innovations performed over the past 5 years?

0.2%

Historical Healthcare annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Insufficient past earnings data to establish if Accelera Innovations's year on year earnings growth rate was positive over the past 5 years.

Unable to compare Accelera Innovations's 1-year growth to the 5-year average as past earnings data has not been reported.

Unable to compare Accelera Innovations's 1-year growth to the US Healthcare Services industry average as past earnings data has not been reported.


Return on Equity

Unable to establish if Accelera Innovations has efficiently used shareholders’ funds last year as no Return on Equity data is available.


Return on Assets

Unable to establish if Accelera Innovations has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as past financial data has not been reported.


Return on Capital Employed

Unable to establish if Accelera Innovations improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to insufficient past data.


Next Steps

Financial Health

How is Accelera Innovations's financial position?


In this section we usually analyse Accelera Innovations's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Accelera Innovations has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of ACNV’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Accelera Innovations's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Accelera Innovations's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Accelera Innovations's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Accelera Innovations's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Accelera Innovations has not reported any payouts.

Unable to verify if Accelera Innovations's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Accelera Innovations has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Accelera Innovations's salary, the management and board of directors tenure and is there insider trading?

6.3yrs

Average management tenure


CEO

Geoff Thompson (51yo)

2.4yrs

Tenure

0

Mr. Geoffrey J. Thompson, also known as Geoff, has been the Chairman of Accelera Innovations, Inc since 2011 and as its Interim Chief Executive Officer and Chief Financial Officer since April 20, 2017. 


Management Age and Tenure

6.3yrs

Average Tenure

67yo

Average Age

The average tenure for the Accelera Innovations management team is over 5 years, this suggests they are a seasoned and experienced team.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Rose Gallagher (68yo)

    President of At Home Health Care Business Unit

    • Tenure: 5.8yrs
  • Geoff Thompson (51yo)

    Chairman of the Board

    • Tenure: 2.4yrs
  • Patrick Custardo (67yo)

    Chief Acquisitions Officer

    • Tenure: 6.8yrs
  • Jimmy LaCaba

    Chief Operating Officer of Advance Lifecare

    • Tenure: 8.3yrs

Board Members

  • John Wallin (69yo)

    Director

    • Tenure: 8.3yrs
    • Compensation: US$131.14k
  • Geoff Thompson (51yo)

    Chairman of the Board

    • Tenure: 2.4yrs

Company Information

Accelera Innovations, Inc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Accelera Innovations, Inc
  • Ticker: ACNV
  • Exchange: OTCPK
  • Founded: 2008
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$188.865k
  • Shares outstanding: 81.41m
  • Website: https://www.accelerainnovations.com

Number of Employees


Location

  • Accelera Innovations, Inc
  • 6039 Thurber Drive
  • Colorado Springs
  • Colorado
  • 80924
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ACNVOTCPK (Pink Sheets LLC)YesCommon StockUSUSDDec 2014

Biography

Accelera Innovations, Inc., a healthcare service company, focuses on the development of Internet-based software in the United States. The company’s Accelera Technology, an Internet-based software platform  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/16 00:20
End of Day Share Price2019/09/13 00:00
Earnings2017/09/30
Annual Earnings2016/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.